Director @ Perceiver Pharmaceuticals (January 2014 - April 2019)
Executive Director @ Neotropix Inc. (September 2007 - November 2014)
Chief Executive Officer - Consulting @ Combinent Biomedical Systems, Inc. (September 2009 - March 2012)
Founder and CEO @ Altus Pharmcaeuticals Inc. (January 1993 - June 2004)
Co-Founder and President @ IG Laboratories Inc. (January 1988 - January 1992)
Controller @ INTEGRATED GENETICS INC (January 1984 - January 1988)
Senior Auditor and Information Systems Specialist @ Deloitte & Touche (January 1979 - January 1984)
Peter Lanciano Education
Bentley University
BS (Accounting and Computer Systems Design)
1975-1979
Bentley University
Peter Lanciano Skills
Entrepreneurship
Drug Discovery
Lifesciences
Start-ups
Corporate Development
Molecular Biology
Cancer
Business Strategy
Oncology
Leadership Development
Strategy
Medical Devices
Clinical Development
Technology Transfer
Entrepreneur
Life Sciences
Strategic Planning
Business Planning
Product Development
Strategy Development
New Business Development
Fundraising
Strategic Partnerships
Contract Negotiation
Research
Team Leadership
Licensing
Joint Ventures
Due Diligence
Diagnostics
Corporate Governance
Auditing
Financial Reporting
Marketing Strategy
Accounting
Start Ups
Public Speaking
Business Development
Internal Controls
Peter Lanciano Summary
Peter Lanciano, based in Milford, MA, US, is currently a Chairman of the Board, Chairman of the Audit and Finance Committee at PeriphaGen Inc. Peter Lanciano brings experience from previous roles at Sojournix, Inc, Perceiver Pharmaceuticals, Neotropix Inc. and Combinent Biomedical Systems, Inc.. Peter Lanciano holds a 1975 - 1979 BS in Accounting and Computer Systems Design @ Bentley University. With a robust skill set that includes Entrepreneurship, Drug Discovery, Lifesciences, Start-ups, Corporate Development and more. Peter Lanciano has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Peter Lanciano?
Find contact details for 700 million professionals.